⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20969271 | 0.68 | — | — | |
| SCHEMBL9872487 | 0.67 | — | — | |
| SCHEMBL20969078 | 0.65 | ALDH1A1 (0.32) | — | |
| SCHEMBL20969195 | 0.65 | ALDH1A1 (0.32) | — | |
| SCHEMBL20969185 | 0.64 | — | — | |
| SCHEMBL20969202 | 0.62 | PSEN1 (0.31) | — | |
| SCHEMBL20969190 | 0.62 | — | — | |
| SCHEMBL20969199 | 0.62 | — | — | |
| SCHEMBL10042221 | 0.60 | MAP3K7 (0.32) | — | |
| SCHEMBL17409120 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6943182-B2 | Cyclopentabenzofuran derivatives and their use | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-13 | — | — | US | claimed |
| EP-1102761-B1 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AG (DE) | 2003-01-29 | — | — | EP | claimed |
| EP-1102761-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | Bayer Aktiengesellschaft (DE) | 2001-05-30 | — | — | EP | claimed |
| WO-2000008007-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-17 | — | — | WO | claimed |
| US-6960640-B2 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2005-11-01 | — | — | US | disclosed |
| US-6943182-B2 | Cyclopentabenzofuran derivatives and their use | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-13 | — | — | US | disclosed |
| US-20040147708-A1 | Composition for optical material | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1426392-A1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-20030144334-A1 | Cyclopentabenzofuran derivatives and their use | GUARNIERI WALTER (DE) | 2003-07-31 | — | — | US | disclosed |
| EP-1102761-B1 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AG (DE) | 2003-01-29 | — | — | EP | disclosed |
| US-6420393-B1 | NUCLEAR FACTOR .KAPPA.B-DEPENDENT DISEASE SELECTED FROM THE GROUP CONSISTING OF INFLAMMATORY DISEASES, IMMUNOLOGICAL DISORDERS, SEPTIC SHOCK, TRANSPLANT REJECTION, RADIATION DAMAGE, REPERFUSION INJURIES AFTER ISCHEMIA, STROKE OR | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | disclosed |
| EP-1102761-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | Bayer Aktiengesellschaft (DE) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008007-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-17 | — | — | WO | disclosed |